(6832217), M. F. A., (6833627), M. L., (133780), D. C., (5234345), S. G., (15267632), L. A., (14085594), H. A. H., . . . (111321), J. G. W. (2023). Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: A model-based cost-utility analysis of data from CONSTRUCT pragmatic trial.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)(6832217), Mohammed Fasihul Alam, Mirella Longo (6833627), David Cohen (133780), Sam Groves (5234345), Laith Alrubaiy (15267632), Hayley A. Hutchings (14085594), Alan Watkins (432126), Shaji Sebastain (15267635), و John G. Williams (111321). Infliximab Versus Ciclosporin in Steroid Resistant Acute Severe Ulcerative Colitis: A Model-based Cost-utility Analysis of Data from CONSTRUCT Pragmatic Trial. 2023.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)(6832217), Mohammed Fasihul Alam, et al. Infliximab Versus Ciclosporin in Steroid Resistant Acute Severe Ulcerative Colitis: A Model-based Cost-utility Analysis of Data from CONSTRUCT Pragmatic Trial. 2023.